BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 23, 2008
View Archived Issues
Rare Pulmonary Fibrosis may Have Blockbuster Potential
A handful of companies are working to develop a treatment for a rare lung disorder called pulmonary fibrosis that, by some estimates, could present a $500 million to $1.5 billion market opportunity. (BioWorld Financial Watch)
Read More
Money Raised By Month
Read More
Stock Winners and Losers For The Week
Read More
Biotechnology Company Deals With Other Biotechnology Companies: May 16 - June 19, 2008
Read More
Biotechnology Company Deals With Miscellaneous Companies: May 16 - June 19, 2008
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: May 16 - June 19, 2008
Read More
Biotech -- Biotech Collaborations: Modified Agreements: May 16 - June 19, 2008
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More